Investor Relations

CAMBRIDGE, Mass., Nov 02, 2010 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for plastics, chemicals and energy, announced today that management will be presenting at the 2010 Stifel Nicolaus Cleantech Conference at 11:30 am ET on November 9, 2010 at the Omni Berkshire Place in New York City.

The Company's 30-minute presentation will take place in the Carnegie Salon and be followed by interactive discussion with participants from the institutional investment community.

In addition to the Company's formal presentation, Joseph Hill, Chief Financial Officer, will also participate in a separate Bioproducts Panel that same morning at 9:45 am ET. The Bioproducts panel will feature participants from a diverse mix of companies in the Bioproducts sector, and will be moderator directed with questions geared toward business strategy and industry outlook.

Interested parties should contact the Stifel Nicolaus Corporate Events Department at (415) 364-2640 for more information on attending.

About Metabolix

Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience company focused on providing sustainable solutions for the world's needs for plastics, chemicals and energy. The Company is taking a systems approach, from gene to end product, integrating sophisticated biotechnology with advanced industrial practice. Metabolix is now developing and commercializing Mirel(TM), a family of high performance bioplastics which are biobased and biodegradable alternatives to many petroleum-based plastics. Metabolix is also developing a proprietary platform technology for co-producing plastics, chemicals and energy, from crops such as switchgrass, oilseeds and sugarcane.

For more information, please visit www.metabolix.com.

(MBLX-E)

SOURCE: Metabolix, Inc.

Metabolix, Inc.
21 Erie Street
Cambridge, MA 02139
617-583-1700
or
Investor Relations:
ICR
James R. Palczynski, 203-682-8229
jp@icrinc.com

Copyright Business Wire 2010